Atos Healthcare muscles up for further UK marketisation prospects:
This article was originally published in Clinica
Executive Summary
Atos Consulting has strengthened its team of UK healthcare business developers, with the appointment of Sunil Patel. Through the French group's London-based Atos Healthcare division, which has already secured important "marketised" NHS service delivery contracts, he will focus on developing business opportunities with the DoH, the NHS and private healthcare organisations. In a veiled reference to the current NHS marketisation drive, Atos said the appointment "demonstrates our commitment to this important and growing market". Mr Patel joins from Accenture, where, over 17 years, he worked on "high-profile NHS projects".
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.